** Engineering solutions firm Emerson raised its full-year profit forecast on Wednesday, expecting steady demand in its unit that makes valves, regulators and actuators
DISCRETE AUTOMATION RECOVERY TO TAKE SOME TIME
** Deutsche Bank ("buy", PT: $138) cheers EMR's robust operational performance for two quarters in row, and expects beat and raise track record to continue in coming quarters
** EMR should benefit from continued process automation market strength and a recovery in its shorter-cycle exposures - DB
** J.P.Morgan ("overweight") says EMR's result "checks the box" and numbers will keep trending higher, the "only thing that matters especially in the context of negative results at peers"
** RBC Capital Markets ("outperform", PT: $140) continues to like co's exposure to array of power trends like energy transition and views power generation valuation attractively
** Adds, pushed order recoveries for test & measurement and discrete automation segments is negative but doesn't disrupt co's growth story
** Stephens ("overweight", PT: $125) says despite slightly longer-than-expected discrete cycle recovery, core trends at EMR are encouraging and views outlook as achievable
(Reporting by Roshan Abraham)
((Roshan.Abraham@thomsonreuters.com))
Comments